Matches 51 - 76 out of 76 < 1 2


Match Document Document Title
US20140302094 VACCINE  
There is provided a NetB epitope polypeptide comprising at least 10 contiguous amino acids from SEQ ID NO:1 and comprising a mutation in at least one position between amino acids 130 and 297 as...
US20100247537 ADJUVANT COMBINATIONS OF NKT ACTIVATOR, CD40 AGONIST, AND OPTIONAL ANTIGEN, THE USE THROUGH INDUCING SYNERGISTIC CELLULAR IMMUNITY  
Adjuvant combinations comprising at least one NKT activator, such as alpha-galactosylceramide (α-Gal-Cer) or iGb3, a CD40 agonist and optionally an antigen are disclosed. The use of these immune...
US20090214466 Methods of Alleviating Disorders and Their Associated Pain  
The invention relates generally to the field of treatment of headache, post-laminectomy syndrome, and other disorders associated with localized pain. The compositions and methods described herein...
US20100166800 RECOMBINANT ATTENUATED CLOSTRIDIUM ORGANISMS AND VACCINE  
The present invention discloses attenuated Clostridium perfringens organisms that express a substantially nontoxic alpha-toxin. The expressed alpha-toxin is a deletion mutein that relative to the...
US20090092639 IMMUNOGENIC COMPOSITION  
Methods and compositions for increasing antibody titer in egg yolks and for using the antibodies are disclosed.
US20100112078 POLYMER PARTICLES BASED VACCINE  
The present invention provides a vaccine composition comprising an effective amount of antigen or a nucleic acid encoding antigen, encapsulated in polymeric particles, wherein said polymeric...
US20130259948 SPRAY DRIED POWDER FORMULATION FOR VACCINES ENTRAPPING ALUM AND THE ANTIGEN IN BIODEGRADABLE POLYMER PARTICLES  
The present invention relates to a novel effective dry powder vaccine formulation that increases the immune response in the host. The formulation comprises of an antigen entrapped into a polymer...
US20090010964 Lipid and Nitrous Oxide Combination as Adjuvant for the Enhancement of the Efficacy of Vaccines  
The invention provides for a method of enhancing immunological responses to an antigen in a vaccine formulation, and for a vaccine formulation that provides for an enhanced immunological response...
US20080069853 Antibody production method  
A method of inducing the sustained release of antibodies in milk comprising the step of: a) implanting at least one antigen releasing device adjacent to, within close proximity of or within at...
US20090169636 Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions  
Immunogenic compositions are described herein which comprise microparticles that further comprise a biodegradable polymer. The microparticle compositions also comprise a cationic polysaccharide...
US20120308618 IC31 NANOPARTICLES  
The invention discloses pharmaceutical compositions in liquid form comprising a peptide with the amino acid sequence KLKL5KLK and an oligodeoxynucleotide with the nucleic acid sequence (dIdC)13...
US20100196423 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases  
The invention relates to the discovery of novel soluble neutral active Hyaluronidase Glycoproteins (sHASEGPs), methods of manufacture, and their use to facilitate administration of other molecules...
US20070065466 Clostridium difficile vaccine  
A vaccine for the treatment or prophylaxis of C. difficile associated disease comprises a C. difficile gene or a C. difficile peptide/polypeptide or a derivative or fragment or mutant or variant...
US20130266583 CLOSTRIDIUM DIFFICILE ANTIGENS  
The present invention relates to recombinant Clostridium difficile antigens based on a fusion protein that consists of or comprises a first amino acid sequence and a second amino acid sequence,...
US20100291152 CHEMICALLY MODIFIED PEPTIDES WITH IMPROVED IMMUNOGENICITY  
The invention provides processes for improving the ability of a peptide to stimulate an immune response, comprising exposing the peptide to a chemical modifying agent. It further provides...
US20170112915 COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS  
It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells...
US20170087197 COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS  
It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells...
US20160256544 ADJUVANTED VACCINES FOR IN OVO AVIAN VACCINATION  
A composition includes at least one mineral oil, a surfactant having a hydrophilic property characterised by an HLB value equal to 12 and a divalent inorganic salt intended to be used as an...
US20160166672 Atoxic recombinant holotoxins of Clostridium difficile as immunogens  
Compositions, methods and kits are provided for preparing an atoxic C. difficile protein that elicits an immune response in the subject specific for TcdA and TcdB. Atoxic Clostridium difficile...
US20160143960 COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS  
It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells...
US20160120968 Compositions and Methods for Immunizing Against C. Difficile  
This disclosure relates to methods for eliciting an immune response against C. difficile toxin A and toxin B in an adult human subject. The subject may be at risk for a primary symptomatic C....
US20160045585 FORMULATIONS  
This invention relates to compositions for delivering one or more active ingredients, and more particularly to compositions, e.g. beads, comprising a matrix material which matrix material...
US20160030542 Toxoid, Compositions and Related Methods  
Methods of producing purified clostridial toxin comprising tangential flow filtration, hydrophobic interaction chromatography and anion exchange chromatography are disclosed. These methods provide...
US20160030349 NANOPARTICLES, METHODS OF PREPARATION, AND USES THEREOF  
The present invention relates to core-shell nanoparticles, methods for their production, and their use, in particular as adjuvants. Generally, the nanoparticles of the invention comprise a solid...
US20150322176 NOVEL POLYSACCHARIDE IMMUNOGENS FROM CLOSTRIDIUM BOLTEAE ISOLATED FROM AUTISTIC SUBJECTS AND METHODS AND USES THEREOF  
The disclosure relates to Clostridium bolteae cell surface polysaccharides, compositions comprising Clostridium bolteae cell surface polysaccharides, and includes kits, methods and uses thereof.
US20150320805 COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS  
It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells...

Matches 51 - 76 out of 76 < 1 2